Dr. Sixten Harborg | Epidemiology | Clinical Research Fellow at Aarhus University Hospital | Denmark
Epidemiology Dr. Sixten Harborg is a physician-scientist specializing in clinical oncology and population-based cancer research, with a strong focus on obesity-related survival disparities in breast cancer. Dr. Sixten Harborg earned his MD from Aarhus University and is completing a fully funded PhD in Clinical Oncology, complemented by extensive international research training at Harvard-affiliated institutions. Dr. Sixten Harborg currently serves as a Junior Doctor in Orthopaedic Surgery and a Clinical Research Fellow in Oncology while maintaining global research collaborations across Europe, the United States, and Oceania. His research interests center on cancer epidemiology, metabolic risk factors, prevention strategies, and guideline development. Dr. Sixten Harborg’s research skills include epidemiologic analysis, clinical trial collaboration, scientific communication, and leadership in international oncology initiatives. His awards include multiple ESMO Young Oncologists Merit Awards and prestigious recognitions from AACR and ESMO. In conclusion, Dr. Sixten Harborg represents a rising leader in epidemiology, advancing evidence-based cancer prevention and clinical practice worldwide.
Citation Metrics (Google Scholar)
500
400
300
200
100
0
.
–
🟦 Citations 🟥 Documents 🟩 h-index
View Google Scholar Profile
Featured Publications
New horizons: epidemiology of obesity, diabetes mellitus, and cancer prognosis
– The Journal of Clinical Endocrinology & Metabolism, 2024
Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis
– NPJ Breast Cancer, 2021
Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study
– Breast Cancer Research and Treatment, 2020
Obesity and risk of recurrence in patients with breast cancer treated with aromatase inhibitors
– JAMA Network Open, 2023
Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study
– Breast Cancer Research and Treatment, 2023